India Market Growth and Financial Performance
India: Amplifying our Core
Lupin prescription business is positioned to outperform
IPM with key drivers in place
Enhancing penetration and reach
• Maximizing Chronic therapy focus
• Sales force expansion
• Grow new areas such as Biosimilars
Inorganic Strategy
.
Target M&A/inorganic activities - mid size
companies, brands & portfolios
New Product Pipeline
• In-house pipeline of novel assets
• In-license via partnerships
Expanding footprint
•
Partnering in e-commerce, organized retail
and institutional business
Empowering
Business Verticals
LUPIN
Enabling end to end healthcare ecosystem and access
for the patient
community
CHC Portfolio catering to GI,
VMS, Cough/cold therapies
Diagnostics platform expanding
across India
Going beyond the pill with
digital offering and patient
neuro-rehab
Building capacity of HCPs and
empowering patients by
education and PSPs¹
Digitally assisting retailers
and channel partners
LUPIN LIFE
Life Inspired by Science
LUPIN
DIAGNOSTICS
Good health starts here
LiFE
ATHARV
ABILITY
A LUPIN INITIATIVE
ABILITY - DIGNITY LIFE
SCIFLIX
HUMRAHI
pharmarack
1 PSPs Patient Support Program
8View entire presentation